Waist Circumference and Cardiovascular Risk Profiles after Autologous Breast Reconstruction: A Nationwide Population-Based Cohort Study.
Jeong Yeop RyuMyeong Jae KangHyun Geun ChoJung Dug YangJoon Seok LeePublished in: Journal of clinical medicine (2023)
To date, few studies have examined changes in waist circumference and cardiovascular risk profile (CVRP) after autologous breast reconstruction. Therefore, this study aimed to investigate the effect of flap surgery using autologous tissue on waist circumference and CVRP through a nationwide population-based cohort study. In total, 6926 patients who underwent autologous breast reconstruction between 2015 and 2019 were considered. Of them, we evaluated 3444 patients who underwent the complete Korean National Health Insurance Service Health Screening (NHIS-HealS) before and after surgery. Body measurements, including waist circumference, weight, and body mass index; and CVRP, including blood pressure, fasting blood glucose, and cholesterol levels, were analyzed by type of surgery up to 3-4 years postoperatively. The body measurements of patients who underwent abdominal-based breast reconstruction were reduced 1-2 years after surgery, but returned to preoperative values 3-4 years after surgery. Regardless of the type of surgery, CVRP was worsened at both 1-2 years and 3-4 years after surgery, except for low-density lipoprotein values. Autologous breast reconstruction did not ameliorate the deterioration of CVRP over time. In addition, the abdominoplasty effect of abdominal-based breast reconstruction disappeared 1-2 years after surgery.
Keyphrases
- breast reconstruction
- body mass index
- end stage renal disease
- blood glucose
- blood pressure
- body weight
- ejection fraction
- chronic kidney disease
- health insurance
- newly diagnosed
- minimally invasive
- healthcare
- mental health
- patients undergoing
- public health
- coronary artery bypass
- stem cells
- low density lipoprotein
- platelet rich plasma
- skeletal muscle
- insulin resistance
- type diabetes
- mesenchymal stem cells
- risk assessment
- physical activity
- quality improvement
- patient reported outcomes
- soft tissue
- glycemic control